Carotid endarterectomy and carotid artery stenting in the light of ICSS and CREST studies
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61383082%3A_____%2F18%3A00000416" target="_blank" >RIV/61383082:_____/18:00000416 - isvavai.cz</a>
Výsledek na webu
<a href="https://www.ncbi.nlm.nih.gov/pubmed/30171320" target="_blank" >https://www.ncbi.nlm.nih.gov/pubmed/30171320</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/978-3-319-73739-3_14" target="_blank" >10.1007/978-3-319-73739-3_14</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Carotid endarterectomy and carotid artery stenting in the light of ICSS and CREST studies
Popis výsledku v původním jazyce
We analyzed the results of internal carotid artery (ICA) stenosis treatment at our institution according to the treatment modality—carotid endarterectomy (CEA) vs. carotid artery stenting (CAS). Methods. During 2003–2015, a total of 1894 procedures were performed for ICA stenosis. CEA was done in 1064 cases and CAS in 830 cases. The primary outcome was disabling stroke (mRS > 2) or myocardial infarction within 30 days of treatment. Secondary outcomes were transitory ischemic attacks (TIAs), minor strokes (stroke without impaired activities of daily living), and any other significant complications. Results. Major mortality and morbidity were divided according to their treatment groups; this reached 0.9% in the CEA and 2.5% in the CAS group (p = 0.007). Minor stroke was recorded at 1.5% and 2.7% in the CEA and CAS groups (p = 0.077), TIAs in 1.0% (CEA) and 4.0% (CAS) (p < 0.001), and any complication in 12.4% (CEA) and 13.0% (CAS) (p = 0.694). Conclusions. CEA is a safe procedure in patients who meet the correct treatment indications. In all subgroup analyses CEA proved to be equal to or better than CAS. This study supports the idea of CEA being the preferred treatment and CAS being reserved for selected cases only.
Název v anglickém jazyce
Carotid endarterectomy and carotid artery stenting in the light of ICSS and CREST studies
Popis výsledku anglicky
We analyzed the results of internal carotid artery (ICA) stenosis treatment at our institution according to the treatment modality—carotid endarterectomy (CEA) vs. carotid artery stenting (CAS). Methods. During 2003–2015, a total of 1894 procedures were performed for ICA stenosis. CEA was done in 1064 cases and CAS in 830 cases. The primary outcome was disabling stroke (mRS > 2) or myocardial infarction within 30 days of treatment. Secondary outcomes were transitory ischemic attacks (TIAs), minor strokes (stroke without impaired activities of daily living), and any other significant complications. Results. Major mortality and morbidity were divided according to their treatment groups; this reached 0.9% in the CEA and 2.5% in the CAS group (p = 0.007). Minor stroke was recorded at 1.5% and 2.7% in the CEA and CAS groups (p = 0.077), TIAs in 1.0% (CEA) and 4.0% (CAS) (p < 0.001), and any complication in 12.4% (CEA) and 13.0% (CAS) (p = 0.694). Conclusions. CEA is a safe procedure in patients who meet the correct treatment indications. In all subgroup analyses CEA proved to be equal to or better than CAS. This study supports the idea of CEA being the preferred treatment and CAS being reserved for selected cases only.
Klasifikace
Druh
J<sub>SC</sub> - Článek v periodiku v databázi SCOPUS
CEP obor
—
OECD FORD obor
30103 - Neurosciences (including psychophysiology)
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2018
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Acta Neurochirurgica, Supplementum
ISSN
00651419
e-ISSN
—
Svazek periodika
129
Číslo periodika v rámci svazku
2018
Stát vydavatele periodika
AT - Rakouská republika
Počet stran výsledku
5
Strana od-do
95-99
Kód UT WoS článku
000455755700014
EID výsledku v databázi Scopus
2-s2.0-85052837902